ANTX vs REGN: Which Stock is Better?

Side-by-side comparison of An2 Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ANTX

An2 Therapeutics Inc

$2.85

REGN

Regeneron Pharmaceuticals Inc

$759.86

Key Metrics Comparison

MetricANTXREGNWinner
Market Cap$46.86M$80.87BREGN
P/E RatioN/A18.45REGN
EPS (TTM)$N/A$41.46REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze ANTX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANTX or REGN a better investment?

Comparing ANTX and REGN: An2 Therapeutics Inc has a market cap of $46.86M while Regeneron Pharmaceuticals Inc has $80.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANTX and REGN?

ANTX (An2 Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANTX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANTX or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for ANTX.

Which company is more profitable: ANTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ANTX.

Which is the larger company: ANTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $80.87B compared to $46.86M for ANTX.

Should I buy ANTX or REGN in 2026?

Both ANTX and REGN have investment merit. ANTX trades at $2.85 while REGN trades at $759.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANTX and REGN stock?

Key differences: Market Cap ($46.86M vs $80.87B), P/E Ratio (N/A vs 18.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons